Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Scientific Reports|January 23, 2026
Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILDYoshihiro Kitahara, Tomoyuki Fujisawa, Atsuki Fukada, et al.
Scientific Reports|April 1, 2026
Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality riskTakuya Masuda, Yasutaka Mochizuka, Yuzo Suzuki, et al.
Translational Lung Cancer Research|August 25, 2021
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinomaXiao-Dong Jiao, Li-Ren Ding, Chuan-Tao Zhang, et al.
Respiratory Investigation|February 1, 2025
Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registryMasato Kono, Noriyuki Enomoto, Yusuke Inoue, et al.
Respiratory Investigation|December 18, 2024
Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational studyHiromasa Nakayasu, Masato Karayama, Noriyuki Enomoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III TrialNaoki Inui, Takahito Suzuki, Kazuki Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung DiseaseAtsuki Fukada, Tomoyuki Fujisawa, Hironao Hozumi, et al.
Scientific Reports|October 13, 2025
Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumoniaShusuke Yazawa, Noriyuki Enomoto, Shogo Nakai, et al.
Respiratory Research|September 28, 2024
CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort studyNoriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, et al.
Scientific Reports|July 19, 2025
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumoniaNoriyuki Enomoto, Masayuki Watanuki, Shogo Nakai, et al.
Pageof 35